Antisense Therapeutics Limited Stock Today
| ATHJF Stock | USD 0.01 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 44
|
Antisense Therapeutics is trading at 0.01 as of the 19th of April 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.01. Antisense Therapeutics has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Antisense Therapeutics Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of April 2022 and ending today, the 19th of April 2024. Click here to learn more.
Antisense Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals in Australia. Antisense Therapeutics Limited was incorporated in 2000 and is based in Toorak, Australia. Antisense Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.. The company has 669.04 M outstanding shares. More on Antisense Therapeutics Limited
Moving together with Antisense Pink Sheet
| 1.0 | LPCUF | Lees Pharmaceutical | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Antisense Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Antisense Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Antisense Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Robert Moses |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Antisense Therapeutics Limited [ATHJF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 41.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Antisense Therapeutics's market, we take the total number of its shares issued and multiply it by Antisense Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Antisense Therapeutics classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 669.04 M outstanding shares.
Antisense Therapeutics Limited has accumulated about 19.23 M in cash with (7.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Antisense Therapeutics Probability Of Bankruptcy
Ownership AllocationAntisense Therapeutics retains a total of 669.04 Million outstanding shares. Antisense Therapeutics Limited shows 19.3 percent of its outstanding shares held by insiders and 4.93 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Antisense Ownership Details
Antisense Stock Against Markets
Picking the right benchmark for Antisense Therapeutics pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Antisense Therapeutics pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Antisense Therapeutics is critical whether you are bullish or bearish towards Antisense Therapeutics Limited at a given time. Please also check how Antisense Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Antisense Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Antisense Therapeutics Corporate Directors
Antisense Therapeutics corporate directors refer to members of an Antisense Therapeutics board of directors. The board of directors generally takes responsibility for the Antisense Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Antisense Therapeutics' board members must vote for the resolution. The Antisense Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Nuket Desem | Director of Clinical and Regulatory Affairs | Profile | |
| Graham Mitchell | Independent Non-Executive Director | Profile | |
| Gary Pace | Non-Executive Director | Profile | |
| William Goolsbee | Non-Executive Director | Profile |
How to buy Antisense Pink Sheet?
Before investing in Antisense Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Antisense Therapeutics. To buy Antisense Therapeutics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Antisense Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Antisense Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Antisense Therapeutics Limited stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Antisense Therapeutics Limited stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Antisense Therapeutics Limited, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Antisense Therapeutics Limited?
The danger of trading Antisense Therapeutics Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Antisense Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Antisense Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Antisense Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Antisense Therapeutics Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in inflation. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Antisense Pink Sheet analysis
When running Antisense Therapeutics' price analysis, check to measure Antisense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Antisense Therapeutics is operating at the current time. Most of Antisense Therapeutics' value examination focuses on studying past and present price action to predict the probability of Antisense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Antisense Therapeutics' price. Additionally, you may evaluate how the addition of Antisense Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |